JITC

Large-scale manufacturing and characterization of CMV-CD19CAR T cells
Xiuli Wang, Ryan Urak, Miriam Walter, Min Guan, Tianxu Han, Vibhuti Vyas, Sheng-Hsuan Chien, Brenna Gittins, Mary C Clark, Sally Mokhtari, Angelo Cardoso, Don J Diamond, John Zaia, Stephen J Forman, Ryotaro Nakamura

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003461; DOI: 10.1136/jitc-2021-003461
Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better
Ming Zheng

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003087; DOI: 10.1136/jitc-2021-003087
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature
Francois Bertucci, Vincent Niziers, Alexandre de Nonneville, Pascal Finetti, Léna Mescam, Olivier Mir, Antoine Italiano, Axel Le Cesne, Jean-Yves Blay, Michele Ceccarelli, Davide Bedognetti, Daniel Birnbaum, Emilie Mamessier

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003687; DOI: 10.1136/jitc-2021-003687
Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity
Shinya Abe, Hiroshi Nagata, Erika J Crosby, Yoshiyuki Inoue, Kensuke Kaneko, Cong-Xiao Liu, Xiao Yang, Tao Wang, Chaitanya R Acharya, Pankaj Agarwal, Joshua Snyder, William Gwin, Michael A Morse, Pei Zhong, Herbert Kim Lyerly, Takuya Osada

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003717; DOI: 10.1136/jitc-2021-003717
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
Malgorzata Bajor, Agnieszka Graczyk-Jarzynka, Katsiaryna Marhelava, Anna Burdzinska, Angelika Muchowicz, Agnieszka Goral, Andriy Zhylko, Karolina Soroczynska, Kuba Retecki, Marta Krawczyk, Marta Klopotowska, Zofia Pilch, Leszek Paczek, Karl-Johan Malmberg, Sébastien Wälchli, Magdalena Winiarska, Radoslaw Zagozdzon

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e002500; DOI: 10.1136/jitc-2021-002500
Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling
Kenichi Makino, Mark D Long, Ryutaro Kajihara, Satoko Matsueda, Takaaki Oba, Kazunori Kanehira, Song Liu, Fumito Ito

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003827; DOI: 10.1136/jitc-2021-003827
Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer
Shingo Maeda, Tomoki Motegi, Aki Iio, Kenjiro Kaji, Yuko Goto-Koshino, Shotaro Eto, Namiko Ikeda, Takayuki Nakagawa, Ryohei Nishimura, Tomohiro Yonezawa, Yasuyuki Momoi

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (2) e003731; DOI: 10.1136/jitc-2021-003731
Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma
Mona O Mohsen, Daniel E Speiser, Justine Michaux, HuiSong Pak, Brian J Stevenson, Monique Vogel, Varghese Philipose Inchakalody, Simone de Brot, Said Dermime, Georges Coukos, Michal Bassani-Sternberg, Martin F Bachmann

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e002927; DOI: 10.1136/jitc-2021-002927
CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors
Chantal L Duurland, Saskia J Santegoets, Ziena Abdulrahman, Nikki M Loof, Gregor Sturm, Tom H Wesselink, Ramon Arens, Sanne Boekestijn, Ilina Ehsan, Mariette I E van Poelgeest, Francesca Finotello, Hubert Hackl, Zlatko Trajanoski, Peter ten Dijke, Veronique M Braud, Marij J P Welters, Sjoerd H van der Burg

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003995; DOI: 10.1136/jitc-2021-003995
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer
Markus Hecht, Markus Eckstein, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Gunther Klautke, Simon Laban, Matthias G Hautmann, Thomas B Brunner, Bálint Tamaskovics, Axel Hinke, Jian-Guo Zhou, Benjamin Frey, Anna-Jasmina Donaubauer, Ina Becker, Sabine Semrau, Arndt Hartmann, Panagiotis Balermpas, Wilfried Budach, Udo S Gaipl, Heinrich Iro, Antoniu-Oreste Gostian, Rainer Fietkau

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003747; DOI: 10.1136/jitc-2021-003747

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages